Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Published:2013-10-03 Issue:14 Volume:369 Page:1317-1326
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Scirica Benjamin M.,Bhatt Deepak L.,Braunwald Eugene,Steg P. Gabriel,Davidson Jaime,Hirshberg Boaz,Ohman Peter,Frederich Robert,Wiviott Stephen D.,Hoffman Elaine B.,Cavender Matthew A.,Udell Jacob A.,Desai Nihar R.,Mosenzon Ofri,McGuire Darren K.,Ray Kausik K.,Leiter Lawrence A.,Raz Itamar

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1307684

Cited by 2960 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs;Diabetes Research and Clinical Practice;2024-10

2. Diabetes-Induced Cardiomyopathy: Updates in Epidemiology, Prevention, and Management;Etiology, Prevention and Management of Cardiomyopathy [Working Title];2024-09-08

3. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06

4. Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large‐scale claim database analysis of Japan;Journal of Diabetes Investigation;2024-09-05

5. The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008;Diabetes, Obesity and Metabolism;2024-09-02